Reaction
Hepatic Haemorrhage reporting signals
As of the last recalculation, Hepatic Haemorrhage appears in 847 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is SORAFENIB (PRR 21.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sorafenib | 18 | 21.7 | 21.8 |
| Amikacin | 14 | 20.5 | 20.5 |
| Fondaparinux Sodium | 5 | 15.3 | 15.3 |
| Lenvatinib | 19 | 14.5 | 14.5 |
| Rifampin | 8 | 13.6 | 13.6 |
| Atezolizumab | 20 | 12.9 | 12.9 |
| Entecavir | 5 | 10.6 | 10.6 |
| Sunitinib Malate | 16 | 10.2 | 10.2 |
| Erlotinib Hydrochloride | 5 | 9.9 | 9.9 |
| Irinotecan Hydrochloride | 5 | 9.6 | 9.6 |
| Rifaximin | 8 | 9.5 | 9.5 |
| Emicizumab | 4 | 8.0 | 8.0 |